UnitedHealth Group Shares Rise Amid Positive Medicare Advantage Ratings Review
UnitedHealth Group’s (NYSE: UNH) shares are on the rise following the company’s preliminary review of its Medicare Advantage ratings. The health insurer announced that it expects 78% of its members to be enrolled in highly rated plans—those with four stars or higher—by 2026. This positive outlook has bolstered investor confidence in the company’s future performance. UNH closed 347.92 (+8.64% today) after bullish headlines and heavy volume, it sits above the 50‑day MA 289.87 and VWAP 342.26, RSI 76 shows momentum, and peers in healthcare showed mixed moves so UNH is pulling sector flows. Risks: stretched RSI (overbought), 200‑day MA at 422.40 as long-term resistance, and any Medicare/quality rating changes could reverse gains (~30% chance).
In addition, senior leaders from UnitedHealth Group are engaging with investors and analysts during a series of meetings taking place from September 8th to September 10th. During these discussions, the company is expected to reaffirm its adjusted earnings per share (EPS) expectations for 2025, further solidifying its growth trajectory.
